Product Images Paroxetine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Paroxetine NDC 68180-647 by Lupin Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a list of drugs with their recommended dosages. The drugs mentioned are Cimetine (300 mg thrice a day), Prensbortisl (100 mg once a day), Penyion (300 mg once a day), Digarin (0.25 mg once a day), and Diazepam (5 mg twice a day). The term "interaction drug" seems to be an incomplete phrase.*
This is a medication called Paroxetine Extended-Release Tablets USP, by Lupin. Each film-coated tablet contains paroxetine hydrochloride hemihydrate USP equivalent to paroxetine 12.5 mg. It contains color additives including FD&C Yellow No. 5 (tartrazine). The usual dosage and storage information is available in accompanying prescribing information. The medication should be dispensed with a medication guide provided separately to each patient. The product should be stored at 25°C (77°F): excursions permitted to 15° to 30°C (59 to 86°F) [see USP Controlled Room Temperature]. The manufacturer is Lupin Pharmaceuticals, Inc. of Baltimore, Maryland, and the medication is manufactured by Lupin Limited of Pithampur (M.P) 454 775, INDIA.*
This is a medication guide for NDC 68180-646-06, which contains paroxetine hydrochloride hemihydrate USP equivalent to paroxetine 25mg. It is an extended-release tablet produced by Lupin Pharmaceuticals. Pharmacists are instructed to dispense with the medication guide provided separately to each patient. The medication should be stored between 15°C to 30°C (59 to 86°F). Physicians should direct the use of safety closures while dispensing it. It also provides the usual dosage and other related information.*
This is a medication description for Paroxetine Extended-Release Tablets. It is advised to dispense with a medication guide provided separately to each patient. It contains Paroxetine hydrochloride hemihydrate USP equivalent to paroxetine 37.5 mg. The recommended usual dosage is specified in the accompanying prescribing information. The medication should be stored at a controlled room temperature of 25°C (77°F) and use safety closures when dispensing unless otherwise directed by the physician or requested by the purchaser. This medication is manufactured for Lupin Pharmaceuticals, Inc. in Baltimore, Maryland, and manufactured by Lupin Limited of Pithampur, India. The text also includes other factual information such as NDC and Rx codes.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.